The DOI matches its Crossref record; 42 of the 42 references it cites were found in a registry or an index.
Human Papillomavirus DNA versus Papanicolaou Screening Tests for Cervical Cancer
Abstract
BACKGROUND: To determine whether testing for DNA of oncogenic human papillomaviruses (HPV) is superior to the Papanicolaou (Pap) test for cervical-cancer screening, we conducted a randomized trial comparing the two methods. METHODS: We compared HPV testing, using an assay approved by the Food and Drug Administration, with conventional Pap testing as a screening method to identify high-grade cervical intraepithelial neoplasia in women ages 30 to 69 years in Montreal and St. John's, Canada. Women with abnormal Pap test results or a positive HPV test (at least 1 pg of high-risk HPV DNA per milliliter) underwent colposcopy and biopsy, as did a random sample of women with negative tests. Sensitivity and specificity estimates were corrected for verification bias. RESULTS: A total of 10,154 women were randomly assigned to testing. Both tests were performed on all women in a randomly assigned sequence at the same session. The sensitivity of HPV testing for cervical intraepithelial neoplasia of grade 2 or 3 was 94.6% (95% confidence interval [CI], 84.2 to 100), whereas the sensitivity of Pap testing was 55.4% (95% CI, 33.6 to 77.2; P=0.01). The specificity was 94.1% (95% CI, 93.4 to 94.8) for HPV testing and 96.8% (95% CI, 96.3 to 97.3; P<0.001) for Pap testing. Performance was unaffected by the sequence of the tests. The sensitivity of both tests used together was 100%, and the specificity was 92.5%. Triage procedures for Pap or HPV testing resulted in fewer referrals for colposcopy than did either test alone but were less sensitive. No adverse events were reported. CONCLUSIONS: As compared with Pap testing, HPV testing has greater sensitivity for the detection of cervical intraepithelial neoplasia. (Current Controlled Trials number, ISRCTN57612064 [controlled-trials.com].).
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Jemal, A., Bray, F., Center, M. M., Ferlay, J., Ward, E., & Forman, D. (2011) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.20107 · Cited by 54,679
Global Cancer Statistics, 2002
Parkin, D. M., Bray, F., Ferlay, J., & Pisani, P. (2005) · CA: A Cancer Journal for Clinicians · doi:10.3322/canjclin.55.2.74 · Cited by 18,196
The 2001 Bethesda System<SUBTITLE>Terminology for Reporting Results of Cervical Cytology</SUBTITLE>
Solomon, D. (2002) · JAMA · doi:10.1001/jama.287.16.2114 · Cited by 3,104
Quadrivalent Vaccine against Human Papillomavirus to Prevent High-Grade Cervical Lesions
(2007) · New England Journal of Medicine · doi:10.1056/nejmoa061741 · Cited by 2,055
Harper, D. M., Franco, E. L., Wheeler, C. M., Moscicki, A.-B., Romanowski, B., Roteli-Martins, C. M., Jenkins, D., Schuind, A., Costa Clemens, S. A., & Dubin, G. (2006) · The Lancet · doi:10.1016/s0140-6736(06)68439-0 · Cited by 1,632
Self-citationVilla, L. L., Costa, R. L., Petta, C. A., Andrade, R. P., Ault, K. A., Giuliano, A. R., Wheeler, C. M., Koutsky, L. A., Malm, C., Lehtinen, M., et al. (2005) · The Lancet Oncology · doi:10.1016/s1470-2045(05)70101-7 · Cited by 1,579
Self-citation2001 Consensus Guidelines for the Management of Women With Cervical Cytological Abnormalities
Wright, Jr. (2002) · JAMA · doi:10.1001/jama.287.16.2120 · Cited by 1,215
Cuzick, J., Clavel, C., Petry, K., Meijer, C. J. L. M., Hoyer, H., Ratnam, S., Szarewski, A., Birembaut, P., Kulasingam, S., Sasieni, P., et al. (2006) · International Journal of Cancer · doi:10.1002/ijc.21955 · Cited by 1,141
Self-citationSolomon, D., Schiffman, M., & Tarone, R. (2001) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/93.4.293 · Cited by 975
American Cancer Society Guidelines for the Early Detection of Cancer, 2006
Smith, R. A., Cokkinides, V., & Eyre, H. J. (2006) · CA: A Cancer Journal for Clinicians · doi:10.3322/canjclin.56.1.11 · Cited by 639
Cited by
Ronco, G., Dillner, J., Elfström, K. M., Tunesi, S., Snijders, P. J. F., Arbyn, M., Kitchener, H., Segnan, N., Gilham, C., Giorgi-Rossi, P., et al. (2014) · The Lancet · doi:10.1016/s0140-6736(13)62218-7 · Cited by 1,810
Saslow, D., Solomon, D., Lawson, H. W., Killackey, M., Kulasingam, S. L., Cain, J., Garcia, F. A. R., Moriarty, A. T., Waxman, A. G., Wilbur, D. C., et al. (2012) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21139 · Cited by 1,390
Self-citationScreening for cervical cancer: U.S. preventive services Task force recommendation statement
Moyer, V. A., & on behalf of the U.S. Preventive Services Task Force* (2012) · Annals of Internal Medicine · doi:10.7326/0003-4819-156-12-201206190-00424 · Cited by 1,049
Saslow, D., Solomon, D., Lawson, H. W., Killackey, M., Kulasingam, S. L., Cain, J. M., Garcia, F. A. R., Moriarty, A. T., Waxman, A. G., Wilbur, D. C., et al. (2012) · Journal of Lower Genital Tract Disease · doi:10.1097/lgt.0b013e31824ca9d5 · Cited by 915
Self-citationEvidence Regarding Human Papillomavirus Testing in Secondary Prevention of Cervical Cancer
Arbyn, M., Ronco, G., Anttila, A., Meijer, C. J. L. M., Poljak, M., Ogilvie, G., Koliopoulos, G., Naucler, P., Sankaranarayanan, R., & Peto, J. (2012) · Vaccine · doi:10.1016/j.vaccine.2012.06.095 · Cited by 897
Saslow, D., Solomon, D., Lawson, H. W., Killackey, M., Kulasingam, S. L., Cain, J., Garcia, F. A. R., Moriarty, A. T., Waxman, A. G., Wilbur, D. C., et al. (2012) · American Journal of Clinical Pathology · doi:10.1309/ajcptgd94evrsjcg · Cited by 791
Self-citationHuman Papillomavirus Testing in the Prevention of Cervical Cancer
Schiffman, M., Wentzensen, N., Wacholder, S., Kinney, W., Gage, J. C., & Castle, P. E. (2011) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djq562 · Cited by 759
Meijer, C. J. L. M., Berkhof, J., Castle, P. E., Hesselink, A. T., Franco, E. L., Ronco, G., Arbyn, M., Bosch, F. X., Cuzick, J., Dillner, J., et al. (2009) · International Journal of Cancer · doi:10.1002/ijc.24010 · Cited by 692
Self-citationDillner, J., Rebolj, M., Birembaut, P., Petry, K.-U., Szarewski, A., Munk, C., de Sanjose, S., Naucler, P., Lloveras, B., Kjaer, S., et al. (2008) · BMJ · doi:10.1136/bmj.a1754 · Cited by 629
Katki, H. A., Kinney, W. K., Fetterman, B., Lorey, T., Poitras, N. E., Cheung, L., Demuth, F., Schiffman, M., Wacholder, S., & Castle, P. E. (2011) · The Lancet Oncology · doi:10.1016/s1470-2045(11)70145-0 · Cited by 570
Screening tests: a review with examples
Maxim, L. D., Niebo, R., & Utell, M. J. (2014) · Inhalation Toxicology · doi:10.3109/08958378.2014.955932 · Cited by 562
Evidence-based clinical guidelines for immigrants and refugees
Pottie, K., Greenaway, C., Feightner, J., Welch, V., Swinkels, H., Rashid, M., Narasiah, L., Kirmayer, L. J., Ueffing, E., MacDonald, N. E., et al. (2011) · Canadian Medical Association Journal · doi:10.1503/cmaj.090313 · Cited by 526
Castle, P. E., Stoler, M. H., Wright, T. C., Sharma, A., Wright, T. L., & Behrens, C. M. (2011) · The Lancet Oncology · doi:10.1016/s1470-2045(11)70188-7 · Cited by 523
Cervical Cancer: An Overview of Pathophysiology and Management
Johnson, C. A., James, D., Marzan, A., & Armaos, M. (2019) · Seminars in Oncology Nursing · doi:10.1016/j.soncn.2019.02.003 · Cited by 382
The known unknowns of HPV natural history
Gravitt, P. E. (2011) · Journal of Clinical Investigation · doi:10.1172/jci57149 · Cited by 378
Evaluation of DNA from the Papanicolaou test to detect ovarian and endometrial cancers.
Kinde, I., Bettegowda, C., Wang, Y., Wu, J., Agrawal, N., Shih, I.-M., Kurman, R., Dao, F., Levine, D. A., Giuntoli, R., et al. (2013) · Science Translational Medicine · doi:10.1126/scitranslmed.3004952 · Cited by 327
Ronco, G., Giorgi-Rossi, P., Carozzi, F., Confortini, M., Palma, P. D., Del Mistro, A., Gillio-Tos, A., Minucci, D., Naldoni, C., Rizzolo, R., et al. (2008) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djn065 · Cited by 306
Cervical cancer prevention: New tools and old barriers
Scarinci, I. C., Garcia, F. A. R., Kobetz, E., Partridge, E. E., Brandt, H. M., Bell, M. C., Dignan, M., Ma, G. X., Daye, J. L., & Castle, P. E. (2010) · Cancer · doi:10.1002/cncr.25065 · Cited by 293
Naucler, P., Ryd, W., Tornberg, S., Strand, A., Wadell, G., Elfgren, K., Radberg, T., Strander, B., Forslund, O., Hansson, B.-G., et al. (2009) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djn444 · Cited by 287
Catarino, R. (2015) · World Journal of Clinical Oncology · doi:10.5306/wjco.v6.i6.281 · Cited by 284
Ogilvie, G. S., van Niekerk, D., Krajden, M., Smith, L. W., Cook, D., Gondara, L., Ceballos, K., Quinlan, D., Lee, M., Martin, R. E., et al. (2018) · JAMA · doi:10.1001/jama.2018.7464 · Cited by 279
Self-citationThe ATHENA human papillomavirus study: design, methods, and baseline results
Wright, T. C., Stoler, M. H., Behrens, C. M., Apple, R., Derion, T., & Wright, T. L. (2012) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2011.07.024 · Cited by 275
Cuschieri, K., & Wentzensen, N. (2008) · Cancer Epidemiology, Biomarkers & Prevention · doi:10.1158/1055-9965.epi-08-0306 · Cited by 273
Cervical Cancer Prevention—Cervical Screening: Science in Evolution
Safaeian, M., Solomon, D., & Castle, P. E. (2007) · Obstetrics and Gynecology Clinics of North America · doi:10.1016/j.ogc.2007.09.004 · Cited by 265
Wentzensen, N., Sherman, M. E., Schiffman, M., & Wang, S. S. (2009) · Gynecologic Oncology · doi:10.1016/j.ygyno.2008.10.012 · Cited by 263
HPV testing as a screen for cervical cancer
Goodman, A. (2015) · BMJ · doi:10.1136/bmj.h2372 · Cited by 262
Tota, J. E., Chevarie-Davis, M., Richardson, L. A., deVries, M., & Franco, E. L. (2011) · Preventive Medicine · doi:10.1016/j.ypmed.2011.08.017 · Cited by 261
Self-citationLeinonen, M., Nieminen, P., Kotaniemi-Talonen, L., Malila, N., Tarkkanen, J., Laurila, P., & Anttila, A. (2009) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djp367 · Cited by 259
Methylation-mediated silencing and tumour suppressive function of hsa-miR-124 in cervical cancer
Wilting, S. M., van Boerdonk, R. A., Henken, F. E., Meijer, C. J., Diosdado, B., Meijer, G. A., le Sage, C., Agami, R., Snijders, P. J., & Steenbergen, R. D. (2010) · Molecular Cancer · doi:10.1186/1476-4598-9-167 · Cited by 258
von Karsa, L., Arbyn, M., De Vuyst, H., Dillner, J., Dillner, L., Franceschi, S., Patnick, J., Ronco, G., Segnan, N., Suonio, E., et al. (2015) · Papillomavirus Research · doi:10.1016/j.pvr.2015.06.006 · Cited by 253
Racey, C. S., Withrow, D. R., & Gesink, D. (2013) · Canadian Journal of Public Health · doi:10.1007/bf03405681 · Cited by 232
Lazcano-Ponce, E., Lorincz, A. T., Cruz-Valdez, A., Salmerón, J., Uribe, P., Velasco-Mondragón, E., Nevarez, P. H., Acosta, R. D., & Hernández-Avila, M. (2011) · The Lancet · doi:10.1016/s0140-6736(11)61522-5 · Cited by 230
Peitzmeier, S. M., Reisner, S. L., Harigopal, P., & Potter, J. (2014) · Journal of General Internal Medicine · doi:10.1007/s11606-013-2753-1 · Cited by 226
Detection of Solid Tumor Molecular Residual Disease (MRD) Using Circulating Tumor DNA (ctDNA)
Chin, R.-I., Chen, K., Usmani, A., Chua, C., Harris, P. K., Binkley, M. S., Azad, T. D., Dudley, J. C., & Chaudhuri, A. A. (2019) · Molecular Diagnosis & Therapy · doi:10.1007/s40291-019-00390-5 · Cited by 191
Bansil, P., Wittet, S., Lim, J. L., Winkler, J. L., Paul, P., & Jeronimo, J. (2014) · BMC Public Health · doi:10.1186/1471-2458-14-596 · Cited by 184
Elfstrom, K. M., Smelov, V., Johansson, A. L. V., Eklund, C., Naucler, P., Arnheim-Dahlstrom, L., & Dillner, J. (2014) · BMJ · doi:10.1136/bmj.g130 · Cited by 142
Gravitt, P. E., Belinson, J. L., Salmeron, J., & Shah, K. V. (2011) · International Journal of Cancer · doi:10.1002/ijc.25974 · Cited by 106
Sewali, B., Okuyemi, K. S., Askhir, A., Belinson, J., Vogel, R. I., Joseph, A., & Ghebre, R. G. (2015) · Cancer Medicine · doi:10.1002/cam4.429 · Cited by 75
Elfgren, K., Elfström, K. M., Naucler, P., Arnheim-Dahlström, L., & Dillner, J. (2017) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2016.10.042 · Cited by 54
Romli, R., Shahabudin, S., Saddki, N., & Mokhtar, N. (2020) · Asian Pacific Journal of Cancer Prevention · doi:10.31557/apjcp.2020.21.3.853 · Cited by 54
Self-Sampling for Human Papillomavirus in a Community Setting: Feasibility in Hispanic Women
De Alba, I., Anton-Culver, H., Hubbell, F. A., Ziogas, A., Hess, J. R., Bracho, A., Arias, C., & Manetta, A. (2008) · Cancer Epidemiology, Biomarkers & Prevention · doi:10.1158/1055-9965.epi-07-2935 · Cited by 54
“Self-sampling in a community setting may be considered in programs using HPV DNA testing alone as primary screening for cervical cancer (24, 25) or, in low resource settings, as part of ‘‘screen and treat’’ approach.”
MethodMartins, T. R., Mendes de Oliveira, C., Rosa, L. R., de Campos Centrone, C., Rodrigues, C. L. R., Villa, L. L., & Levi, J. E. (2016) · Virology Journal · doi:10.1186/s12985-016-0594-3 · Cited by 42
Maza, M., Melendez, M., Masch, R., Alfaro, K., Chacon, A., Gonzalez, E., Soler, M., Conzuelo-Rodriguez, G., Gage, J. C., Alonzo, T. A., et al. (2018) · Preventive Medicine · doi:10.1016/j.ypmed.2018.06.017 · Cited by 37
Quincy, B. L., Turbow, D. J., & Dabinett, L. N. (2012) · Journal of Obstetrics and Gynaecology · doi:10.3109/01443615.2011.625456 · Cited by 36
“…sensitivity for the detection of high-grade cervical lesions compared with cytology alone (Kuhn et al. 2000; Schiff man et al. 2000; Kulasingam et al. 2002; Cuzick et al. 2003; Salmeron et al. 2003; Pereira et al. 2005; Ronco et al. 2006; Mayrand et al. 2007; Ronco et al. 2008; Ronco et al. 2010).”
BackgroundKang, L.-N., Jeronimo, J., Qiao, Y.-L., Zhao, F.-H., Chen, W., Valdez, M., Zhang, X., Bansil, P., Paul, P., Bai, P., et al. (2014) · Journal of Clinical Microbiology · doi:10.1128/jcm.03432-13 · Cited by 21
Coutlée, F., de Pokomandy, A., Burchell, A. N., El‐Zein, M., Mayrand, M., Rodrigues‐Coutlée, S., Money, D., Comète, É., McClymont, E., Rouleau, D., et al. (2022) · Journal of Medical Virology · doi:10.1002/jmv.27605 · Cited by 15
Self-citationMarcuccilli, F., Farchi, F., Mirandola, W., Ciccozzi, M., Paba, P., Bonanno, E., Perno, C. F., & Ciotti, M. (2015) · Journal of Virological Methods · doi:10.1016/j.jviromet.2015.02.018 · Cited by 15
Bukowski, A., Hoyo, C., Hudgens, M. G., Brewster, W. R., Valea, F., Bentley, R. C., Vidal, A. C., Maguire, R. L., Schmitt, J. W., Murphy, S. K., et al. (2022) · Cancer Epidemiology, Biomarkers & Prevention · doi:10.1158/1055-9965.epi-22-0054 · Cited by 9
Utility of Human Papillomavirus Testing for Cervical Cancer Screening in Korea.
Kim, M.-S., Lee, E. H., Park, M.-I., Lee, J. S., Kim, K., Roh, M. S., & Lee, H. W. (2020) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph17051726 · Cited by 7
Metadata
- Authors
- Mayrand, M.-H., Duarte-Franco, E., Rodrigues, I., Walter, S. D., Hanley, J., Ferenczy, A., Ratnam, S., Coutlée, F., & Franco, E. L.
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2007-10-18
- Volume
- 357
- Issue
- 16
- Pages
- 1579-1588
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2114212562
- Cited by
- 1,100
- References
- 42
- FWCI
- 55.48
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.